NKTREUR Nektar Therapeutics

held by 1 manager in Q1 2017

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	1.02%	3 mo	NEW	$16M	665,600

Search